ATLANTA BRAVES HOLDINGS IN-C (BATRK) Fundamental Analysis & Valuation

NASDAQ:BATRKUS0477263026

Current stock price

50.07 USD
+0.66 (+1.34%)
At close:
50.07 USD
0 (0%)
After Hours:

This BATRK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BATRK Profitability Analysis

1.1 Basic Checks

  • BATRK had negative earnings in the past year.
  • In the past year BATRK had a positive cash flow from operations.
  • In the past 5 years BATRK always reported negative net income.
  • BATRK had a positive operating cash flow in each of the past 5 years.
BATRK Yearly Net Income VS EBIT VS OCF VS FCFBATRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • With a Return On Assets value of -1.45%, BATRK perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
  • BATRK has a Return On Equity of -4.44%. This is comparable to the rest of the industry: BATRK outperforms 59.49% of its industry peers.
  • With a decent Return On Invested Capital value of 1.06%, BATRK is doing good in the industry, outperforming 65.82% of the companies in the same industry.
Industry RankSector Rank
ROA -1.45%
ROE -4.44%
ROIC 1.06%
ROA(3y)-3.94%
ROA(5y)-2.97%
ROE(3y)-11.37%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
BATRK Yearly ROA, ROE, ROICBATRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20 -25

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.27%, BATRK is in the better half of the industry, outperforming 65.82% of the companies in the same industry.
  • With a Gross Margin value of 30.19%, BATRK is not doing good in the industry: 65.82% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BATRK has declined.
Industry RankSector Rank
OM 2.27%
PM (TTM) N/A
GM 30.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.03%
GM growth 5Y-20.67%
BATRK Yearly Profit, Operating, Gross MarginsBATRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100

0

2. BATRK Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BATRK is destroying value.
  • Compared to 1 year ago, BATRK has more shares outstanding
  • The number of shares outstanding for BATRK has been increased compared to 5 years ago.
  • The debt/assets ratio for BATRK is higher compared to a year ago.
BATRK Yearly Shares OutstandingBATRK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
BATRK Yearly Total Debt VS Total AssetsBATRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.54, we must say that BATRK is in the distress zone and has some risk of bankruptcy.
  • BATRK has a Altman-Z score (1.54) which is in line with its industry peers.
  • BATRK has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.18, BATRK is doing worse than 67.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACC0.12
WACC8.71%
BATRK Yearly LT Debt VS Equity VS FCFBATRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • BATRK has a Current Ratio of 0.42. This is a bad value and indicates that BATRK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BATRK's Current ratio of 0.42 is on the low side compared to the rest of the industry. BATRK is outperformed by 82.28% of its industry peers.
  • BATRK has a Quick Ratio of 0.42. This is a bad value and indicates that BATRK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BATRK has a Quick ratio of 0.42. This is amonst the worse of the industry: BATRK underperforms 82.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
BATRK Yearly Current Assets VS Current LiabilitesBATRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

7

3. BATRK Growth Analysis

3.1 Past

  • BATRK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.00%, which is quite impressive.
  • The Revenue has grown by 10.52% in the past year. This is quite good.
  • BATRK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.70% yearly.
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y7.6%
Revenue growth 5Y32.7%
Sales Q2Q%17.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 32.82% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 48.29% on average over the next years. This is a very strong growth
EPS Next Y139.62%
EPS Next 2Y68.28%
EPS Next 3Y32.82%
EPS Next 5YN/A
Revenue Next Year8.54%
Revenue Next 2Y6.88%
Revenue Next 3Y6.72%
Revenue Next 5Y48.29%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BATRK Yearly Revenue VS EstimatesBATRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
BATRK Yearly EPS VS EstimatesBATRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 3

1

4. BATRK Valuation Analysis

4.1 Price/Earnings Ratio

  • BATRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • BATRK is valuated quite expensively with a Price/Forward Earnings ratio of 324.08.
  • BATRK's Price/Forward Earnings is on the same level as the industry average.
  • BATRK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.36.
Industry RankSector Rank
PE N/A
Fwd PE 324.08
BATRK Price Earnings VS Forward Price EarningsBATRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200 300

4.2 Price Multiples

  • BATRK's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 42.23
BATRK Per share dataBATRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BATRK does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as BATRK's earnings are expected to grow with 32.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.28%
EPS Next 3Y32.82%

0

5. BATRK Dividend Analysis

5.1 Amount

  • No dividends for BATRK!.
Industry RankSector Rank
Dividend Yield 0%

BATRK Fundamentals: All Metrics, Ratios and Statistics

ATLANTA BRAVES HOLDINGS IN-C

NASDAQ:BATRK (5/1/2026, 4:30:01 PM)

After market: 50.07 0 (0%)

50.07

+0.66 (+1.34%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Industry Strength48.45
Industry Growth59.01
Earnings (Last)02-25
Earnings (Next)05-11
Inst Owners76.28%
Inst Owner Change0.14%
Ins Owners5.4%
Ins Owner Change0.52%
Market Cap3.20B
Revenue(TTM)732.49M
Net Income(TTM)-23.37M
Analysts84
Price Target59.61 (19.05%)
Short Float %16.12%
Short Ratio4.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47%
Min EPS beat(2)-13.41%
Max EPS beat(2)107.41%
EPS beat(4)3
Avg EPS beat(4)39.43%
Min EPS beat(4)-13.41%
Max EPS beat(4)107.41%
EPS beat(8)5
Avg EPS beat(8)17.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.25%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)14.24%
Revenue beat(4)3
Avg Revenue beat(4)9.65%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)23.88%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-8.42%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)-1.53%
PT rev (3m)-3.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.11%
EPS NY rev (1m)0%
EPS NY rev (3m)175%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 324.08
P/S 4.37
P/FCF N/A
P/OCF 126.8
P/B 6.08
P/tB 14.12
EV/EBITDA 42.23
EPS(TTM)-0.39
EYN/A
EPS(NY)0.15
Fwd EY0.31%
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)0.39
OCFY0.79%
SpS11.46
BVpS8.23
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.45%
ROE -4.44%
ROCE 1.34%
ROIC 1.06%
ROICexc 1.15%
ROICexgc 1.56%
OM 2.27%
PM (TTM) N/A
GM 30.19%
FCFM N/A
ROA(3y)-3.94%
ROA(5y)-2.97%
ROE(3y)-11.37%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.03%
GM growth 5Y-20.67%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Debt/EBITDA 6.74
Cap/Depr 191.77%
Cap/Sales 19.8%
Interest Coverage 0.41
Cash Conversion 27.36%
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.54
F-Score6
WACC8.71%
ROIC/WACC0.12
Cap/Depr(3y)141.98%
Cap/Depr(5y)99.98%
Cap/Sales(3y)14.52%
Cap/Sales(5y)10.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.9%
EPS Next Y139.62%
EPS Next 2Y68.28%
EPS Next 3Y32.82%
EPS Next 5YN/A
Revenue 1Y (TTM)10.52%
Revenue growth 3Y7.6%
Revenue growth 5Y32.7%
Sales Q2Q%17.62%
Revenue Next Year8.54%
Revenue Next 2Y6.88%
Revenue Next 3Y6.72%
Revenue Next 5Y48.29%
EBIT growth 1Y141.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11195.1%
EBIT Next 3Y416.77%
EBIT Next 5Y300.78%
FCF growth 1Y-72.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.74%
OCF growth 3Y-21.91%
OCF growth 5YN/A

ATLANTA BRAVES HOLDINGS IN-C / BATRK Fundamental Analysis FAQ

What is the fundamental rating for BATRK stock?

ChartMill assigns a fundamental rating of 3 / 10 to BATRK.


What is the valuation status for BATRK stock?

ChartMill assigns a valuation rating of 1 / 10 to ATLANTA BRAVES HOLDINGS IN-C (BATRK). This can be considered as Overvalued.


Can you provide the profitability details for ATLANTA BRAVES HOLDINGS IN-C?

ATLANTA BRAVES HOLDINGS IN-C (BATRK) has a profitability rating of 3 / 10.


How financially healthy is ATLANTA BRAVES HOLDINGS IN-C?

The financial health rating of ATLANTA BRAVES HOLDINGS IN-C (BATRK) is 0 / 10.


What is the expected EPS growth for ATLANTA BRAVES HOLDINGS IN-C (BATRK) stock?

The Earnings per Share (EPS) of ATLANTA BRAVES HOLDINGS IN-C (BATRK) is expected to grow by 139.62% in the next year.